Your session is about to expire
← Back to Search
Incidental training for Language Disorder (IACT Trial)
N/A
Waitlist Available
Led By Seth Wiener, PhD
Research Sponsored by Carnegie Mellon University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 3 months post-intervention
Awards & highlights
IACT Trial Summary
This trial will help researchers understand how people learn speech categories by studying how adult second-language learners use perceptual building blocks.
Eligible Conditions
- Language Disorder
- Healthy Subjects
IACT Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, 3 months post-intervention
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 3 months post-intervention
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in phonetic cue weighting after 2 months of training
Change in phonological category learning after 2 months of training
Change in word learning after 2 months of training
Secondary outcome measures
Transfer of new linguistic abilities to unrelated language after 2 months of training
IACT Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Incidental trainingExperimental Treatment1 Intervention
Participants undergo novel non-linguistic incidental category learning training.
Group II: explicit trainingActive Control1 Intervention
Participants undergo traditional explicit language learning.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Incidental training
2019
N/A
~190
Find a Location
Who is running the clinical trial?
Carnegie Mellon UniversityLead Sponsor
76 Previous Clinical Trials
539,743 Total Patients Enrolled
Seth Wiener, PhDPrincipal InvestigatorCarnegie Mellon University
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any remaining positions open to participants in this trial?
"This trial, which was initially listed on September 1st 2019 and last modified November 15th 2022, is not currently accepting patients. However, 845 other trials are open for recruitment at the moment."
Answered by AI
Share this study with friends
Copy Link
Messenger